Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Amir Elstein joins Teva's board of directors

This article was originally published in Scrip

Executive Summary

Teva Pharmaceutical Industries(Israel) has appointed Amir Elstein to its board of directors. Mr Elstein has been a member of Teva's senior management since 2005 and most recently served as executive vice-president of global pharmaceutical resources. Before joining Teva as an executive officer, Mr Elstein served on the company's board of directors from 1995 to 2004. He has resigned his executive position with Teva in order to rejoin its board of directors.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC007665

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel